Articles tagged #Diabetes on Vitalspell.
Artificial sweeteners and cognitive decline were linked in a large Neurology cohort, but the study was observational and strongest in adults with diabetes.
A phase 2 randomized trial published in JAMA Network Open found that HTD1801, an oral compound combining berberine with ursodeoxycholic acid, reduced HbA1c by 1.0 percentage point over 12 weeks. The drug also improved insulin sensitivity, lipid profiles, and liver enzyme levels, with two phase 3 trials now completed and an NDA submission planned.
